Senior insider sale
Chief Executive Officer at ITEOS THERAPEUTICS, INC. — senior position signals high conviction
$1.06M
104.56K shares
What this filing means
DETHEUX MICHEL plans to sell 104.56K shares of ITEOS THERAPEUTICS, INC. valued at approximately $1.06M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/5/2025ACC: 0001969223-25-000401
DirectorOfficer· Chief Executive Officer
Since Jul 2020
104.56K
Shares to sell
$1.06M
Approx. market value
52.28K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
6/5/2025
52.28KTotal acquired52.28K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/5/2025 | Exercise of Stock Options Cash | 52.28K | — |
| Total | 52.28K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
43.88K
Market value
$443.3K
6/4/2025
—Completed
Units to sell
8.40K
Market value
$84.8K
6/4/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
52.28K
Market value
$534.3K
6/5/2025
Total
Units
104.56K
Value
$1.06M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/4/2025 | 43.88K | $443.3K | — | Completed |
6/4/2025 | 8.40K | $84.8K | — | Completed |
| Planned — Approximate Date | ||||
6/5/2025 | 52.28K | $534.3K | Nasdaq | Planned |
| Total | 104.56K | $1.06M | ||